Side Effect Management | News

Why I View the Cancer Treatment-Related Changes of My Body With Humor

December 7th 2021

By Julie S. Brokaw

An ovarian cancer survivor describes the changes her body endured after treatment and explains why she chooses to laugh at them.

The Ins and Outs of Risk Stratification, Managing Side Effects and Survivorship in Breast Cancer

December 6th 2021

By Colleen Moretti

Patients who understand their roles and responsibilities may better help their care teams understand what they may be at risk for in their cancer survivorship.

FDA Denies Approval for Plinabulin Plus G-CSF in Current Form for Chemotherapy Induced Neutropenia

December 1st 2021

By Colleen Moretti

The FDA issued a complete response letter stating there was not enough sufficient evidence that the combination demonstrated a benefit.

Immunotherapy Side Effects: ‘No Organ System Potentially Unaffected’

November 23rd 2021

By Brielle Benyon

Immunotherapy side effects are a different than those of chemotherapy and other cancer treatments. Patients should know when to seek emergency care and what to communicate to clinicians.

Side Effects, Costs Can Be ‘Game Changers’ in Deciding MCL Treatment

November 19th 2021

By Brielle Benyon

With three BTK inhibitors approved for treatment of mantle cell lymphoma, patients and providers should consider side effects and insurance coverage before deciding on a drug.

Certain Cancer Immunotherapies May Lead to ‘Potential Small Risk’ for Myocarditis

November 17th 2021

By Darlene Dobkowski, MA

Although the risk for myocarditis related to immune checkpoint inhibitors is an estimated 1%, findings from a recent study highlight the need for improved ways to screen and treat for this potential side effect.

Patients With Cancer Should ‘Keep Moving Through Treatment’ to Potentially Mitigate Side Effects

November 9th 2021

By Darlene Dobkowski, MA

Exercising during and after cancer treatment remains important for patients and building up endurance over time can help make goals less daunting, an expert said.

Side Effects From Immune Checkpoint Inhibitors May Increase Hospitalizations, Cost for Patients With Bladder, Liver, Lung or Skin Cancer

November 4th 2021

By Colleen Moretti

Patients who experience side effects due to immune checkpoint inhibitors are 80% more likely to go to the emergency room and have 30% higher monthly medical costs, compared to patients who did not have side effects.

FDA’s New Recommendations on Risk of Breast Implants an ‘Enormous Step Forward’ For Patients With Breast Cancer

November 4th 2021

By Ryan McDonald

The FDA’s recommendations are aimed at helping individuals and patients with breast cancer make better informed decisions about the decision to receive breast implants, according to experts.

Medical Marijuana Use May Aid in Breast Cancer Symptom Management

November 3rd 2021

By Darlene Dobkowski, MA

Patients with breast cancer are turning to medical marijuana to manage symptoms of their disease and treatment, although conversation with health care teams are not occurring as often.